Article
Genome Editing for Familial Hemophagocytic Lymphohistiocytosis: Design Principles, Challenges, and Translational Perspectives.
Human gene therapy - 1 Aug 2026
Minaiyan Ghazale, Aussel Clotilde, Ammann Sandra, Cathomen Toni
Abstract excerpt
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome caused by genetic defects in cytotoxic lymphocyte function. Current therapies can control disease activity, but transplantation of allogeneic hematopoietic stem and progenitor cells (HSPCs) remains the only curative option and is associated with substantial risks. These limitations have accelerated development of genome...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
